Keros Therapeutics Inc (KROS) Annual Balance Sheets

Annual · GAAP · USD millions
Access KROS quarterly Balance Sheets →
Tracking balance sheet results across Keros Therapeutics Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent287.42
Cash & Short-term Investments287.00
Accounts receivable3.57
Income Taxes Receivable, Current NO2.25
Prepaid Expense And Other Assets Current22.20
Total Current Assets315.43
Equipment/Property/Plant Net4.30
Other Assets, Noncurrent18.29
Operating Lease Right Of Use Asset16.84
Restricted Cash Noncurrent1.45
Total Assets338.02
Liabilities
Accounts Payable, Current AC1.97
Accrued Liabilities, Current AC16.04
Other Liabilities, Current2.41
Total Current Liabilities20.41
Total Long-term Debt0.00
Other liabilities, Noncurrent14.48
Operating Lease Liability Current2.41
Operating Lease Liability Noncurrent14.48
Total Liabilities34.89
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,169.45
Retained Earnings / Accumulated Deficit-481.77
Other Equity-384.56
Common Stockholder's Equity303.13
Total Stockholder's Equity303.13
Liabilities & Stockholder's Equity338.02
4 historic quarters locked

Sign in to unlock the full Keros Therapeutics Inc balance sheet history.

About Keros Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001664710-26-000018

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License